Source: IQVIA National Sales Perspectives, IQVIA Institute, Dec 2017
Chart notes: New brands are protected branded products on the market less than 24 months during the year reported. Protected brands are products that are no longer “new” and have yet to reach patent expiry. Loss of Exclusivity (LOE) are brands that were once protected and have since lost patent protection. Generics include both unbranded and branded generics. All segments are mutually exclusive in each time period. Includes all medicines in both pharmacy and institutional settings. Charted values may not sum due to rounding.
Source -
Source +
25.3
3.1
2.7
9.9
3.7
17.3
-11.3
26.2
12.1
-0.7
1.4
3.6
5.7
14.3
-2.2
1.7
5.3
2.1
6.7
20.7
-10.2
3.2
2.7
2.2
3.9
7.0
6.2
-18.8
.07
1.5
5.2
12.0
-12.5
-5.0
-0.5
Total growth fell to $0.7Bn, new and protected brands saw a $4.8Bn decrease from 2016, and generics declined by $5.5Bn.
The impact of loss of exclusivity has been largely unchanged for the last four years.
Growth slowed in 2016 and declined by $5.5Bn in 2017. While generic prices had been going up, they are now trending drastically downward.
Generic growth had been a positive driver of growth from 2013–2015 as the combinationof fewer expiries and price increases lifted spending.
Protected brand net volume growth slowed in 2017 to $1.5Bn. This trend is in part due to earlier-launched brands becoming more mature or declining as they faced competition from generics and/or newer brands.
Protected brands added $5.2 billion to spending in 2017 just due to price increases. Significantly lower than the $18 billion of invoice price growth before discounts and rebates.
The largest drivers of net spending growth in 2017 were new brands on the market for less than 24 months. While they accounted for $12 billion in new spending, this is down from the historically high level seen in 2014-2016.
-12.5
12.0
5.2
1.5
5.7
1.4
3.6
14.3
-12.2
-0.7
-11.3
17.3
9.9
2.7
3.1
2.1
-10.2
20.7
6.7
5.3
1.7
3.9
2.7
2.2
7.0
6.2
-18.8
Chart 4: Net Spending Growth by Product Type US$Bn
Overall total net medicine spending has actually slowed to $0.7Bn
View Full Graph
View charts to learn more about net spending growth
in U.S. dollars (in billions) by product type
View Full Graph
Total
LOE
Generic Prices
Generic Volume
Protected Brands Volume
Protected Brands Price
tap key to explore
New Brands
2017
2017
2016
2016
2015
2015
2014
2014
2013
2013
0.7
1.5
5.2
12.0
-12.5
-0.5
12.1
25.3
26.2
3.2
